Ultrasound zaps brain to fight addiction in tiny new trial
NCT ID NCT06474026
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This early study tests a device that uses focused ultrasound to target a brain region linked to addiction. Ten adults with stimulant use disorder will receive either a sham or real treatment. The goal is to see if it's safe and can help them stay drug-free for up to 6 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ExAblate 4000 Type 2.1 (focused ultrasound device)
- What this could lead to
- If it works, this could offer a new way to help people with stimulant addiction stay off drugs by reducing cravings.
- What could go wrong
- This is a very early feasibility study with only 10 people. It may not work, and the effects might not last. Risks of the brain procedure are unknown.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSYCHOSTIMULANT USE DISORDER(PUD) are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Korea University Anam Hospital
RECRUITINGSeoul, Seoul, 02841, South Korea